• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EPIC Norfolk 研究中结直肠癌中 PTEN 和 PIK3CA 的改变:与临床病理和饮食因素的关联。

Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors.

机构信息

Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.

出版信息

BMC Cancer. 2011 Apr 7;11:123. doi: 10.1186/1471-2407-11-123.

DOI:10.1186/1471-2407-11-123
PMID:21473780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3080834/
Abstract

BACKGROUND

The PTEN tumour suppressor gene and PIK3CA proto-oncogene encode proteins which contribute to regulation and propagation of signal transduction through the PI3K/AKT signalling pathway. This study investigates the prevalence of loss of PTEN expression and mutations in both PTEN and PIK3CA in colorectal cancers (CRC) and their associations with tumour clinicopathological features, lifestyle factors and dietary consumptions.

METHODS

186 adenocarcinomas and 16 adenomas from the EPIC Norfolk study were tested for PTEN and PIK3CA mutations by DNA sequencing and PTEN expression changes by immunohistochemistry. Dietary and lifestyle data were collected prospectively using seven day food diaries and lifestyle questionnaires.

RESULTS

Mutations in exons 7 and 8 of PTEN were observed in 2.2% of CRC and PTEN loss of expression was identified in 34.9% CRC. Negative PTEN expression was associated with lower blood low-density lipoprotein concentrations (p = 0.05). PIK3CA mutations were observed in 7% of cancers and were more frequent in CRCs in females (p = 0.04). Analysis of dietary intakes demonstrated no link between PTEN expression status and any specific dietary factor. PTEN expression negative, proximal CRC were of more advanced Dukes' stage (p = 0.02) and poor differentiation (p < 0.01). Testing of the prevalence of PIK3CA mutations and loss of PTEN expression demonstrated that these two events were independent (p = 0.55).

CONCLUSION

These data demonstrated the frequent occurrence (34.9%) of PTEN loss of expression in colorectal cancers, for which gene mutations do not appear to be the main cause. Furthermore, dietary factors are not associated with loss of PTEN expression. PTEN expression negative CRC were not homogenous, as proximal cancers were associated with a more advanced Dukes' stage and poor differentiation, whereas distal cancers were associated with earlier Dukes' stage.

摘要

背景

PTEN 肿瘤抑制基因和 PIK3CA 原癌基因编码的蛋白质有助于调节和传播通过 PI3K/AKT 信号通路的信号转导。本研究调查了在结直肠癌 (CRC) 中 PTEN 表达缺失和 PTEN 和 PIK3CA 突变的发生率及其与肿瘤临床病理特征、生活方式因素和饮食摄入的关系。

方法

通过 DNA 测序检测来自 EPIC Norfolk 研究的 186 例腺癌和 16 例腺瘤中的 PTEN 和 PIK3CA 突变,并用免疫组化检测 PTEN 表达变化。通过 7 天食物日记和生活方式问卷前瞻性收集饮食和生活方式数据。

结果

PTEN 外显子 7 和 8 的突变在 2.2%的 CRC 中观察到,PTEN 表达缺失在 34.9%的 CRC 中被识别。PTEN 表达阴性与较低的血液低密度脂蛋白浓度相关(p=0.05)。PIK3CA 突变在 7%的癌症中观察到,在女性 CRC 中更为常见(p=0.04)。饮食摄入分析表明,PTEN 表达状态与任何特定的饮食因素之间没有联系。PTEN 表达阴性、近端 CRC 的 Dukes 分期更高(p=0.02)和分化较差(p<0.01)。检测 PIK3CA 突变和 PTEN 表达缺失的患病率表明,这两个事件是独立的(p=0.55)。

结论

这些数据表明,PTEN 表达缺失在结直肠癌中频繁发生(34.9%),基因突变似乎不是主要原因。此外,饮食因素与 PTEN 表达缺失无关。PTEN 表达阴性的 CRC 并不均匀,因为近端癌症与更晚期的 Dukes 分期和较差的分化相关,而远端癌症与更早的 Dukes 分期相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4826/3080834/4a62117dd590/1471-2407-11-123-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4826/3080834/d841f6ba59be/1471-2407-11-123-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4826/3080834/a3e619581066/1471-2407-11-123-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4826/3080834/a45006569d17/1471-2407-11-123-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4826/3080834/4a62117dd590/1471-2407-11-123-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4826/3080834/d841f6ba59be/1471-2407-11-123-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4826/3080834/a3e619581066/1471-2407-11-123-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4826/3080834/a45006569d17/1471-2407-11-123-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4826/3080834/4a62117dd590/1471-2407-11-123-4.jpg

相似文献

1
Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors.EPIC Norfolk 研究中结直肠癌中 PTEN 和 PIK3CA 的改变:与临床病理和饮食因素的关联。
BMC Cancer. 2011 Apr 7;11:123. doi: 10.1186/1471-2407-11-123.
2
Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia.马来西亚吉隆坡一所三级医院的结直肠癌中 Ras-Raf-丝裂原活化蛋白激酶和磷脂酰肌醇 3-激酶-Akt 信号通路的分子改变。
APMIS. 2013 Oct;121(10):954-66. doi: 10.1111/apm.12152. Epub 2013 Aug 29.
3
PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer.PIK3CA 和 PTEN 基因及外显子突变与结直肠癌的临床病理及分子相关性。
Clin Cancer Res. 2013 Jun 15;19(12):3285-96. doi: 10.1158/1078-0432.CCR-12-3614. Epub 2013 Apr 30.
4
Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study.饮食、生活方式和临床病理因素与 EPIC Norfolk 研究中不同结直肠肿瘤亚群中 BRAF 和 K-ras 突变相关。
BMC Cancer. 2010 Mar 16;10:99. doi: 10.1186/1471-2407-10-99.
5
PIK3CA alterations in Middle Eastern ovarian cancers.中东地区卵巢癌中的PIK3CA基因改变
Mol Cancer. 2009 Jul 28;8:51. doi: 10.1186/1476-4598-8-51.
6
A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.肺癌中 PI3K/AKT/mTOR 通路的详细免疫组化分析:与 PIK3CA、AKT1、K-RAS 或 PTEN 基因突变状态及临床病理特征的相关性。
Oncol Rep. 2013 Aug;30(2):623-36. doi: 10.3892/or.2013.2512. Epub 2013 May 31.
7
Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence?PTEN缺失及磷酸肌醇3激酶/蛋白激酶B通路在散发性结直肠肿瘤中的临床病理意义:PTEN缺失是局部复发的预测指标吗?
Am J Surg. 2008 Jun;195(6):719-25. doi: 10.1016/j.amjsurg.2007.05.061. Epub 2008 Apr 28.
8
Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma.胃癌中PTEN的频繁单等位基因缺失及其与PIK3CA扩增的相互关联。
Int J Cancer. 2003 Apr 10;104(3):318-27. doi: 10.1002/ijc.10962.
9
Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis.子宫内膜癌中PI3K-AKT和p53的伴随改变与预后不良相关。
Mod Pathol. 2009 Apr;22(4):522-9. doi: 10.1038/modpathol.2009.5. Epub 2009 Feb 20.
10
KRAS, BRAF and PIK3CA mutations and the loss of PTEN expression in Chinese patients with colorectal cancer.中国结直肠癌患者 KRAS、BRAF 和 PIK3CA 基因突变及 PTEN 表达缺失。
PLoS One. 2012;7(5):e36653. doi: 10.1371/journal.pone.0036653. Epub 2012 May 7.

引用本文的文献

1
Biological and Clinical Characteristics of Proximal Colon Cancer: Far from Its Anatomical Subsite.近端结肠癌的生物学和临床特征:与其解剖亚部位相去甚远。
Int J Med Sci. 2024 Jul 9;21(10):1824-1839. doi: 10.7150/ijms.97574. eCollection 2024.
2
Integrative Enhancer Discovery Reveals a New Model of Enhancer Organization.整合增强子发现揭示了增强子组织的新模式。
bioRxiv. 2023 Sep 21:2023.09.20.558459. doi: 10.1101/2023.09.20.558459.
3
Platelet detection as a new liquid biopsy tool for human cancers.血小板检测作为一种用于人类癌症的新型液体活检工具。

本文引用的文献

1
Activation of K-RAS by co-mutation of codons 19 and 20 is transforming.密码子19和20共同突变导致的K-RAS激活具有转化作用。
J Mol Signal. 2011 Mar 3;6:2. doi: 10.1186/1750-2187-6-2.
2
Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study.饮食、生活方式和临床病理因素与 EPIC Norfolk 研究中不同结直肠肿瘤亚群中 BRAF 和 K-ras 突变相关。
BMC Cancer. 2010 Mar 16;10:99. doi: 10.1186/1471-2407-10-99.
3
Bias in odds ratios by logistic regression modelling and sample size.
Front Oncol. 2022 Sep 14;12:983724. doi: 10.3389/fonc.2022.983724. eCollection 2022.
4
Clinicopathological Significance of PTEN Expression and Its Prognostic Effect in Colorectal Adenocarcinoma Patients.PTEN表达在结直肠癌患者中的临床病理意义及其预后影响
Iran J Pathol. 2022 Spring;17(2):150-158. doi: 10.30699/IJP.2021.531779.2653. Epub 2022 Mar 8.
5
Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers.对 34129 例结直肠癌中 PTEN 突变谱进行全面特征分析。
Nat Commun. 2022 Mar 25;13(1):1618. doi: 10.1038/s41467-022-29227-2.
6
Any Role of PIK3CA and PTEN Biomarkers in the Prognosis in Oral Squamous Cell Carcinoma?PIK3CA和PTEN生物标志物在口腔鳞状细胞癌预后中起作用吗?
Life (Basel). 2020 Dec 3;10(12):325. doi: 10.3390/life10120325.
7
Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?改变与在癌症管理中的作用:我们是否在精准医学方面取得了进展?
Genes (Basel). 2020 Jun 28;11(7):719. doi: 10.3390/genes11070719.
8
Mechanism of Apoptosis Induced by Curcumin in Colorectal Cancer.姜黄素诱导结直肠癌细胞凋亡的机制。
Int J Mol Sci. 2019 May 17;20(10):2454. doi: 10.3390/ijms20102454.
9
Mechanistic Insights into Colorectal Cancer Phenomics from Fundamental and Organotypic Model Studies.从基础和器官型模型研究看结直肠癌表型的机制见解。
Am J Pathol. 2018 Sep;188(9):1936-1948. doi: 10.1016/j.ajpath.2018.05.021. Epub 2018 Jul 18.
10
PTEN controls glandular morphogenesis through a juxtamembrane β-Arrestin1/ARHGAP21 scaffolding complex.PTEN 通过一个跨膜 β-Arrestin1/ARHGAP21 支架复合物控制腺体形态发生。
Elife. 2017 Jul 27;6:e24578. doi: 10.7554/eLife.24578.
比值比的偏倚与逻辑回归模型和样本量。
BMC Med Res Methodol. 2009 Jul 27;9:56. doi: 10.1186/1471-2288-9-56.
4
Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant.原发性结直肠癌及其相关转移部位中表皮生长因子受体(EGFR)和下游蛋白的不同程度失调可能具有临床相关性。
Br J Cancer. 2009 Apr 7;100(7):1087-94. doi: 10.1038/sj.bjc.6604848. Epub 2009 Mar 17.
5
Class I PI3K in oncogenic cellular transformation.I类磷脂酰肌醇-3激酶在致癌性细胞转化中的作用
Oncogene. 2008 Sep 18;27(41):5486-96. doi: 10.1038/onc.2008.244.
6
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?结直肠锯齿状息肉和癌症中的BRAF、KRAS及PIK3CA突变:结直肠癌发生过程中的原发性或继发性遗传事件?
BMC Cancer. 2008 Sep 9;8:255. doi: 10.1186/1471-2407-8-255.
7
Novel mutations of the suppressor gene PTEN in colorectal carcinomas stratified by microsatellite instability- and TP53 mutation- status.根据微卫星不稳定性和TP53突变状态分层的结直肠癌中抑癌基因PTEN的新突变
Hum Mutat. 2008 Nov;29(11):E252-62. doi: 10.1002/humu.20860.
8
Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population.中东人群中携带PIK3CA突变的结直肠癌的临床病理分析
Oncogene. 2008 Jun 5;27(25):3539-45. doi: 10.1038/sj.onc.1211013. Epub 2008 Jan 14.
9
PIK3CA cancer mutations display gender and tissue specificity patterns.PIK3CA癌症突变呈现出性别和组织特异性模式。
Hum Mutat. 2008 Feb;29(2):284-8. doi: 10.1002/humu.20648.
10
PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients.PTEN表达缺失可预测西妥昔单抗对转移性结直肠癌患者的疗效。
Br J Cancer. 2007 Oct 22;97(8):1139-45. doi: 10.1038/sj.bjc.6604009. Epub 2007 Oct 16.